241 related articles for article (PubMed ID: 10391015)
1. [Eradication of Helicobacter pylori in Japan].
Kamimoto H; Fukuda Y; Tamura K; Shimoyama T
Nihon Rinsho; 1999 Jun; 57(6):1435-41. PubMed ID: 10391015
[TBL] [Abstract][Full Text] [Related]
2. [History of the treatment of Helicobacter pylori and clinical efficacy].
Yamamoto I; Fukuda Y; Shimoyama T
Nihon Rinsho; 1999 Jan; 57(1):32-42. PubMed ID: 10036933
[TBL] [Abstract][Full Text] [Related]
3. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
Leodolter A; Peitz U; Malfertheiner P
Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
5. [Helicobacter pylori infection].
Kubota T; Fujioka T; Nasu M
Rinsho Byori; 1998 Jul; 46(7):623-8. PubMed ID: 9721527
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease].
Habu Y; Kiyota K; Inokuchi H; Sugano Y; Ko K; Waki S
Nihon Rinsho; 1999 Jan; 57(1):135-9. PubMed ID: 10036950
[TBL] [Abstract][Full Text] [Related]
7. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
8. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
9. [Helicobacter pylori in peptic ulcer and gastric cancer].
Matsukura N; Onda M; Yamashita K
Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection in the Caribbean: update in management.
Lee MG; Barrow KO; Edwards CN
West Indian Med J; 2001 Mar; 50(1):8-10. PubMed ID: 11398298
[TBL] [Abstract][Full Text] [Related]
11. [Risk factor Helicobacter pylori. Prevention of stomach carcinoma].
MMW Fortschr Med; 2005 May; 147(20):53. PubMed ID: 15957864
[No Abstract] [Full Text] [Related]
12. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
14. [Peptic ulcer disease in liver cirrhosis: role of Helicobacter pylori infection and therapeutic approach].
Mitrică D; Constantinescu R; Drug VL; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):27-32. PubMed ID: 21688556
[TBL] [Abstract][Full Text] [Related]
15. [Helicobacter pylori--overview of therapy].
Katicić M; Prskalo M; Tićak M; Sabarić B; Marusić M; Banić M; Buljevac M; Kujundzić M; Jelić D; Kozić M; Mihaljević S; Mićunović Z; Skurla B; Filipec T
Lijec Vjesn; 2002 Sep; 124 Suppl 1():72-8. PubMed ID: 12592823
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
17. What is new related to Helicobacter pylori infection in children and teenagers?
Kato S; Sherman PM
Arch Pediatr Adolesc Med; 2005 May; 159(5):415-21. PubMed ID: 15867113
[TBL] [Abstract][Full Text] [Related]
18. [Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer].
Shirai T; Kurumada T; Kouda K; Watanabe S; Tada U; Wada T; Takagi A; Harasawa S; Miwa T
Nihon Rinsho; 1999 Jan; 57(1):140-3. PubMed ID: 10036951
[No Abstract] [Full Text] [Related]
19. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.
Hunt RH
Am J Gastroenterol; 1997 Apr; 92(4 Suppl):36S-40S; discussion 40S-43S. PubMed ID: 9127625
[TBL] [Abstract][Full Text] [Related]
20. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Pajdo R; Drozdowicz D; Ptak A; Pawlik M; Stachura J; Pawlik WW; Hahn EG
J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
